Boot Camp (HEMA 910)
Given the importance of Biotechnology in the current market, science-literate managers are not only desirable but essential. The purpose is to provide the enabling language to understand the current biotech literature for students who do not have a science background.
Every quarter we have a Saturday event where Practitioners affiliated with products and services will be invited to provide a vision of the current and future developments as well as the needs in the health enterprise sector.
Cutting Edge Technologies
February 23, 2013, Jacob's Room 1246, 8:30am-12:30pm
Douglas Losordo, MD,Vice President, New Therapeutic Development, Baxter Healthcare
Regenerative Medicine: New Approaches in the 21st Century
Nicholas Marsh, Senior Director, Drug Discovery & Development, Adnexus - Bristol Myers Squibb company
Adnectins as New Generation of Targeted Therapeutics
Percy Van Crocker Jr, Vice President, Commercial Development, AuraSense Therapeutics
Nanotechnology for Gene Regulation
information, contact Sangeeta